NewsBenzinga몬테 로사 테라퓨틱스, ACR 컨버전스 2026에서 MRT-8102의 전임상 데이터 발표 몬테 로사 테라퓨틱스, ACR 컨버전스 2026에서 MRT-8102의 전임상 데이터 발표 Benzinga 2026.11.09 12:23 (GMT+0) Open on Benzinga Other news Barclays Downgrades Fresenius Medical Care to Underweight Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ImmunityBio And Rafa Laboratories Say Israeli MoH Grants Approval For ANKTIVA, Indicated In Combination With BCG For Treatment Of Adult Patients With BCG-Unresponsive NMIBC With CIS With Or Without Papillary Tumors Monte Rosa Therapeutics Presents Preclinical Data Of MRT-8102 At ACR Convergence 2026 B of A Securities Initiates Coverage On Supernus with Buy Rating, Announces Price Target of $47 Freedom Broker Upgrades Dnow to Buy, Maintains Price Target to $18
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
ImmunityBio And Rafa Laboratories Say Israeli MoH Grants Approval For ANKTIVA, Indicated In Combination With BCG For Treatment Of Adult Patients With BCG-Unresponsive NMIBC With CIS With Or Without Papillary Tumors
